Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial

Autor: Li, Xiaobo, Ge, Zhen, Kan, Jing, Anjum, Muhammed, Ye, Fei, Gao, Xiaofei, Jalal, Anjum, Xie, Ping, Tao, Ling, Chen, Xiang, Khan, Hamid S, Javed, Asim, Shao, Yibin, Guo, Xiaomei, Li, Feng, Saghir, Tahir, Mengal, Naeem, Nie, Shaoping, Qu, Hong, Qian, Xuesong, Yang, Song, Chen, Jing, Gao, Dasheng, Liu, Lijun, Wang, Mingliang, Chen, Lianglong, Liu, Fan, Xu, Tan, Liu, Yinwu, Gill, Badar Ul Ahad, Yang, Qing, Guo, Nin, Wen, Shangyu, Cong, Hongliang, Hong, Lang, Sheiban, Imad, Raza, Afsar, Wei, Yongyue, Chen, Feng, Mintz, Gary S, Zhang, Jun-Jie, Stone, Gregg W, Chen, Shao-Liang, Mohydin, Bilal S, Gao, Fentang, Shao, Yibing, Wang, Yan, Zeng, Hesong, Khan, Hamid Sharif
Zdroj: In The Lancet 11-17 May 2024 403(10439):1866-1878
Databáze: ScienceDirect